×
About 4,045 results

ALLMedicine™ Aspergillosis Center

Research & Reviews  1,456 results

Antimycotic Drugs and their Mechanisms of Resistance to Candida Species.
https://doi.org/10.2174/1389450122666210719124143
Current Drug Targets; Dahiya S, Sharma N et. al.

Sep 24th, 2021 - Fungal infections have shown an upsurge in recent decades, which is mainly because of the increasing number of immunocompromised patients and the occurrence of invasive candidiasis has been found to be 7-15 fold greater than that of invasive asper...

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibr...
https://doi.org/10.1002/14651858.CD010288.pub5
The Cochrane Database of Systematic Reviews; Jat KR, Walia DK et. al.

Sep 23rd, 2021 - Cystic fibrosis is an autosomal recessive multisystem disorder with an approximate prevalence of 1 in 3500 live births. Allergic bronchopulmonary aspergillosis is a lung disease caused by aspergillus-induced hypersensitivity with a prevalence of 2...

Xanthogranulomatous pyelonephritis due to Aspergillus in a non-diabetic older patient.
https://doi.org/10.1136/bcr-2021-245067
BMJ Case Reports; Khilar N, Gupta N et. al.

Sep 18th, 2021 - Xanthogranulomatous pyelonephritis is a rare condition characterised by destructive granulomatous inflammation of renal parenchyma. Primary renal Aspergillosis has been reported in patients with immunocompromised states such as diabetes, retrovira...

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441945
Critical Care (London, England); Hatzl S, Reisinger AC et. al.

Sep 17th, 2021 - Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19-associated severe acute respiratory failure (ARF). Whether mould active antifungal prophylaxis (MAFP) c...

Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in ...
https://doi.org/10.1080/14737167.2021.1981862
Expert Review of Pharmacoeconomics & Outcomes Research; Beauchemin C, Guinan K et. al.

Sep 16th, 2021 - BackgroundInvasive mold infections (IMI) directly impact life expectancy, especially with delayed therapy. Among IMI, aspergillosis (IA) is more common than mucormycosis (IM), resulting in IA-targeted empirical treatment with voriconazole for susp...

see more →

Guidelines  8 results

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727169
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.

Aug 31st, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...

ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates a...
https://doi.org/10.1016/j.cmi.2019.05.019
Clinical Microbiology and Infection : the Official Public... Warris A, Lehrnbecher T et. al.

Jun 4th, 2019 - Presenting symptoms, distributions and patterns of diseases and vulnerability to invasive aspergillosis (IA) are similar between children and adults. However, differences exist in the epidemiology and underlying conditions, the usefulness of newer...

Individualized Medication of Voriconazole: A Practice Guideline of the Division of Ther...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250289
Therapeutic Drug Monitoring; Chen K, Zhang X et. al.

Sep 8th, 2018 - Voriconazole (VRZ) is a second-generation triazole antifungal agent with broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily indicated for treating invasive aspergillosis. The most commonly used dos...

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-...
https://doi.org/10.1016/j.cmi.2018.01.002
Clinical Microbiology and Infection : the Official Public... Ullmann AJ, Aguado JM et. al.

Mar 17th, 2018 - The European Society for Clinical Microbiology and Infectious Diseases, the European Confederation of Medical Mycology and the European Respiratory Society Joint Clinical Guidelines focus on diagnosis and management of aspergillosis. Of the numero...

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormyc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394968
Haematologica Tissot F, Agrawal S et. al.

Dec 25th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...

see more →

Drugs  88 results see all →

News  65 results

Doctors Search for Missing Link Between COVID and ITP
https://www.medscape.com/viewarticle/944801

Jan 27th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hospitalist Sarah Stone, MD, arrived for her dayshift at Sharp Chula Vista in California one day in late December. The ICU and hospital wards were...

The COVID Complication You Might Miss
https://www.medscape.com/viewarticle/940740_2

Nov 19th, 2020 - COVID-Associated Pulmonary Aspergillosis (CAPA)   CAPA is a recently recognized complication of COVID-19. Although aspergillosis is classically associated with severely immunocompromised patients, it is increasingly detected in patients who receiv...

PJP prophylaxis may be unnecessary for CLL patients on BTK inhibitors
https://www.mdedge.com/chestphysician/article/210199/cll/pjp-prophylaxis-may-be-unnecessary-cll-patients-btk-inhibitors?channel=234
Sharon Worcester, MDedge News

Oct 16th, 2019 - EDINBURGH – Routine empiric prophylaxis against pneumocystis jiroveci pneumonia (PJP) may be unwarranted in chronic lymphocytic leukemia patients initiating Bruton tyrosine kinase (BTK) inhibitor therapy, a retrospective chart review suggests. Dr.

Myositis Patients at High Risk of Opportunistic Infections
https://www.medpagetoday.com/rheumatology/generalrheumatology/82747

Oct 15th, 2019 - Among patients with systemic rheumatic diseases, the highest incidence of opportunistic infections was seen in those with polymyositis/dermatomyositis (PM/DM), Taiwanese researchers found. In a nationally representative cohort study, the incidence...

Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man
https://www.mdedge.com/fedprac/article/171981/hematology/fatal-drug-resistant-invasive-pulmonary-aspergillus-fumigatus-56/page/0/2?channel=327

Aug 14th, 2019 - Conclusion This fatal case of invasive pulmonary aspergillosis illustrates the importance of considering the 4 main causes of treatment failure in an infection. Although the patient had a high burden of disease with a rare resistance pattern, he w.

see more →

Patient Education  1 results see all →